Mumbai: A rest house for cancer patients and their relatives has been refurbished and commissioned at Central Railway's Dr Babasaheb Ambedkar Memorial Railway Hospital at Byculla in south Mumbai, officials said today.
The Cancer Patient and Relatives Rest House has dormitories for men and women patients besides 32 rooms for supervisors and relatives, said CR officials.
It was inaugurated by CR general manager DK Sharma yesterday.
"In order to mitigate the sufferings of outstation patients and relatives, Central Railway has constructed a Patient and Relatives Rest House for relatives and care givers of patients admitted for treatment to the zonal hospital at Byculla as well as the Tata Memorial Hospital," a CR statement said.
These rooms and dormitories are well furnished with cots, mattresses, pillows, chairs, refrigerators, RO drinking water purifiers among other amenities, CR officials said.
The 366-bed Dr Babasaheb Ambedkar Hospital at Byculla is among the premier medical facilities in the railway's health apparatus and is also home to the only medical oncologist on the Indian Railway system, officials said.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!